CaaMTech to Talk Aeruginascin at Pharmacology 2020

Dr. Andrew Chadeayne will speak at the British Pharmacological Society’s Pharmacology 2020 conference

Pharmacology 2020 Logo

CaaMTech CEO, Dr. Andrew Chadeayne, will present at the British Pharmacological Society’s Pharmacology 2020 conference in a session titled “Recent Findings on Psychedelics for Treating Mental Illness.”  Dr. Chadeayne will discuss CaaMTech’s research that investigated aeruginascin, its active metabolite, 4-HO-TMT, and a novel synthetic prodrug of the latter.  The research, titled Active Metabolite of Aeruginascin (4-HydroxyN,N,Ntrimethyltryptamine): Synthesis, Structure, and Serotonergic Binding Affinity was published in July in the American Chemical Society’s prestigious peer-reviewed journal, ACS Omega.

The session, “Recent Findings on Psychedelics for Treating Mental Illness”, will be hosted by Prof. Dr. Craig Lindsley of Vanderbilt University.  In addition to his role as Professor of Pharmacology, Biochemistry, & Chemistry, Dr. Lindsley is Director of Medicinal Chemistry in the Vanderbilt Program in Drug Discovery and Director of the Vanderbilt Specialized Chemistry Center (MLPCN), and will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (WCNDD) on December 1st.

Dr. Chadeayne will join renowned psychedelic researchers Drs. Charles Nichols, David Olson and Kim Kuypers in giving talks for the session.  Dr. Charles D. Nichols was Louisiana State University’s most-cited researcher in 2019 where he focuses his research efforts on the 5-HT2A receptor and works as a Professor of Pharmacology. Dr. David E. Olson’s lab at the University of California Davis focuses on psychoplastogens and Dr. Olson has co-authored numerous peer-reviewed research articles on the effects of N,N-dimethyltryptamine (DMT) and related compounds.  Dr. Kim P.C. Kuypers is an Associate Professor with the Faculty of Psychology and Neuroscience at Maastricht University where she conducts social neuropsychopharmacological research with psychedelics.

The Pharmacology 2020 conference is described by British Pharmacological Society organizers as, “an exciting multi-day online event made up of scientific sessions, interactive workshops and social activities.”  For health and safety reasons due to the global coronavirus pandemic, the conference will take place virtually from December 14-18, 2020.  The deadline to register for the conference is December 5th.  More information about the conference can be found on the Pharmacology 2020 event website.